Array BioPharma

Quick facts

Phase 1 pipeline

• ARRY-403, glucokinase activator; oral · Diabetes
  Glucokinase activator
• Gemcitabine, nucleoside analogue; intravenous

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Array BioPharma portfolio CI brief
• Array BioPharma pipeline updates RSS